Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Source: psychiatryadvisor.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Outcomes Reduction. Real-time updates on events, politics, business and more.